MedTrace Logo

Vytorin Reexamination Study (0653A-174)

NCT01070966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2089

Last updated 2022-02-09

Study results available
· View outcomes & findings →

Summary

This survey is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the clinical usefulness of VYTORIN through collecting the safety and efficacy information according to the Re-examination Regulation for New Drugs.

Conditions

  • Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2010-04-30
Completion
2010-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01070966 on ClinicalTrials.gov